LABT · Lakewood-Amedex Biotherapeutics Inc.
$1.96
-0.08 (-3.92%)
At close · Jul 29
Going-concern doubt
— flagged May 22, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued has not been alleviated.”View the 10-Q filed May 22, 2026
Market Cap
$12.94M
Shares
7.00M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Joseph Tucker | member of the Board | Appointed | 2026-04-28 |